Hefei Hengxin Life Science and Technology
301501
Triductor Technology
688259
Zhejiang Sf Oilless Bearing Co.,Ltd.
300817
4
Shenzhen Riland Industry Group
300154
5
Chengdu TangYuan Electric
300789
US Stock MarketDetailed Quotes
SKYE SKYE BIOSCIENCE INC
- 2.290
- -0.240-9.49%
Close Mar 18 16:00 ET
69.47MMarket Cap4.32P/E (TTM)
2.500High2.270Low187.72KVolume2.500Open2.530Pre Close438.91KTurnover1.25%Turnover RatioLossP/E (Static)30.34MShares17.64752wk High0.92P/B34.48MFloat Cap2.27052wk Low--Dividend TTM15.06MShs Float64.725Historical High--Div YieldTTM9.09%Amplitude1.440Historical Low2.338Avg Price1Lot Size
SKYE BIOSCIENCE INC Stock Forum
Sign in to post a comment
HK down today but portfolio is still looking good!
$Novonix (NVX.AU)$ and $Energy Transition Minerals Ltd (ETM.AU)$
coming through for me today, on paper and real account so it's a very happy day!!
I've believed in nvx for a number of years. Watching it in downtrend after covid and market crash and sky high interest rates (they had a lot of debts) was disheartening. But I was patient and waited, when it hit .40 I went in a few thousand. It's paying off already an...
$Novonix (NVX.AU)$ and $Energy Transition Minerals Ltd (ETM.AU)$
coming through for me today, on paper and real account so it's a very happy day!!
I've believed in nvx for a number of years. Watching it in downtrend after covid and market crash and sky high interest rates (they had a lot of debts) was disheartening. But I was patient and waited, when it hit .40 I went in a few thousand. It's paying off already an...
+5
2
2
There are a handful of tickers in medical and/or cannabis pharma I've had on my watchlists or bought into..
While some caught my eye early, there are others I've just recently become aware of.
Many Oz companies can grow, produce and distribute overseas... quite a lot of international companies base growing/distribution operations in Europe, some can produce or grow here but only distribute their products overseas.. some are able to produce, grow, develop and distribute do...
While some caught my eye early, there are others I've just recently become aware of.
Many Oz companies can grow, produce and distribute overseas... quite a lot of international companies base growing/distribution operations in Europe, some can produce or grow here but only distribute their products overseas.. some are able to produce, grow, develop and distribute do...
4
1
1
$Veru Inc (VERU.US)$ $Newton Golf (SPGC.US)$ $TuHURA Biosciences (HURA.US)$ $Reborn Coffee (REBN.US)$ $Siyata Mobile (SYTA.US)$ $SKYE BIOSCIENCE INC (SKYE.US)$ $Envirotech Vehicles (EVTV.US)$ $Nextracker (NXT.US)$ $Ranpak Holdings (PACK.US)$ $Lucas GC (LGCL.US)$ $60 Degrees Pharmaceuticals (SXTP.US)$ $Banzai International (BNZI.US)$ $Silexion Therapeutics (SLXN.US)$ $Signing Day Sports (SGN.US)$ $36KR Holdings (KRKR.US)$
📊⚡️📊
📊⚡️📊
6
1
$SKYE BIOSCIENCE INC (SKYE.US)$ Reuters· 1 min ago
Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor
Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor
$SKYE BIOSCIENCE INC (SKYE.US)$
Skye Bioscience Comments on Monlunabant Phase 2 Top-line Data and Reiterates Confidence in Nimacimab Clinical Development Plan
Skye Bioscience (Nasdaq: SKYE) has commented on Novo Nordisk's Phase 2a top-line data for monlunabant, a small-molecule oral CB1 inverse agonist. The study met its primary endpoint, showing at least 6% placebo-adjusted weight loss at 16 weeks. However, dose-dependent neuropsychiatric side effects were observed.
Skye highlights the advan...
Skye Bioscience Comments on Monlunabant Phase 2 Top-line Data and Reiterates Confidence in Nimacimab Clinical Development Plan
Skye Bioscience (Nasdaq: SKYE) has commented on Novo Nordisk's Phase 2a top-line data for monlunabant, a small-molecule oral CB1 inverse agonist. The study met its primary endpoint, showing at least 6% placebo-adjusted weight loss at 16 weeks. However, dose-dependent neuropsychiatric side effects were observed.
Skye highlights the advan...
1
$SKYE BIOSCIENCE INC (SKYE.US)$
Skye Bioscience Launches Phase 2 CBeyond Clinical Trial of its Differentiated CB1 Inhibitor, Nimacimab, in Patients with Obesity. Skye Bioscience (Nasdaq: SKYE) has launched a Phase 2 clinical trial, CBeyond™, to evaluate its peripheral CB1 inhibitor, nimacimab, for weight loss in patients with obesity.
The study will assess nimacimab's efficacy as a monotherapy and in combination with a GLP-1 receptor agonist (Wegovy®). Key aspects of the trial include:
- 12...
Skye Bioscience Launches Phase 2 CBeyond Clinical Trial of its Differentiated CB1 Inhibitor, Nimacimab, in Patients with Obesity. Skye Bioscience (Nasdaq: SKYE) has launched a Phase 2 clinical trial, CBeyond™, to evaluate its peripheral CB1 inhibitor, nimacimab, for weight loss in patients with obesity.
The study will assess nimacimab's efficacy as a monotherapy and in combination with a GLP-1 receptor agonist (Wegovy®). Key aspects of the trial include:
- 12...
$Scorpius Holdings (SCPX.US)$ Look at their peers. This is really undervalued. Once in a lifetime opporturnity.
$SKYE BIOSCIENCE INC (SKYE.US)$ $Boundless Bio (BOLD.US)$
$SKYE BIOSCIENCE INC (SKYE.US)$ $Boundless Bio (BOLD.US)$
1
$SKYE BIOSCIENCE INC (SKYE.US)$
![]()
this just shows it pays to follow up on things..
I had been eyeing this off for a while. Tried to buy in Jan at 0.019-0.020 but then left it alone as for whatever reason I wasn't able to buy.
Now I see it's gone from 0.02000 to a whopping 3.15.
Damn you Mr Market, that's ice cold!
I had been eyeing this off for a while. Tried to buy in Jan at 0.019-0.020 but then left it alone as for whatever reason I wasn't able to buy.
Now I see it's gone from 0.02000 to a whopping 3.15.
Damn you Mr Market, that's ice cold!
3
No comment yet
Trending Stocks
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Moomoo Lily : Hello, regarding the issue you reported with the paper trading, we have verified with the relevant technical team: due to web network latency, the interface operations for simulated trading may experience some delays. We kindly ask for your patience and to wait a moment after each operation. Thank you for your feedback.
MooMamaLlama OP Moomoo Lily : @Moomoo Lily Hi Lily! thanks for the fast response with an actual answer that makes sense! We all appreciate it more than you know